Sally E. Abu‐Risha

Zinc oxide nanoparticles and a standard antidiabetic drug restore the function and structure of beta cells in Type-2 diabetes

Rehab Mohmed El-Gharbawy, Ashraf M. Emara, Sally E. Abu‐Risha · Biomedicine & Pharmacotherapy · 2016 · 123 citations

Nanomedicine, Diabetes Management, Engineering +12

Octreotide and melatonin alleviate inflammasome-induced pyroptosis through inhibition of TLR4-NF-κB-NLRP3 pathway in hepatic ischemia/reperfusion injury

Alaa E. El‐Sisi, Samia Salim Sokar, Abdelhadi M. Shebl et al. · Toxicology and Applied Pharmacology · 2020 · 82 citations

Inflammation, Hepatic Ischemia/reperfusion Injury, Medicine +15

Targeting autophagy to modulate hepatic ischemia/reperfusion injury: A comparative study between octreotide and melatonin as autophagy modulators through AMPK/PI3K/AKT/mTOR/ULK1 and Keap1/Nrf2 signaling pathways in rats

Dina Zakaria Mohamed, Alaa E. El‐Sisi, Samia Salim Sokar et al. · European Journal of Pharmacology · 2021 · 49 citations

Inflammation, Cell Autophagy, Mitophagy +14

Protective role of irbesartan against cyclophosphamide-induced testicular damage in rats via up-regulating PPAR-γ signaling and ameliorating NF-κB/NLRP3/IL-18 inflammatory axis

Sally E. Abu‐Risha, Mai A. Mousa, Alaa E. El‐Sisi · Life Sciences · 2021 · 39 citations

Inflammation, Cytokine, Anti-inflammatory +12

Targeting MDR‐1 gene expression, BAX/BCL2, caspase‐3, and Ki‐67 by nanoencapsulated imatinib and hesperidin to enhance anticancer activity and ameliorate cardiotoxicity

Alaa E. El‐Sisi, Samia Salem Sokkar, Hanaa A. Ibrahim et al. · Fundamental and Clinical Pharmacology · 2020 · 38 citations